Raxorulimogene belzovacirepvec transgene (IgGL

Approval Year

Substance Class	Nucleic Acid Created by `admin` on `Sat Dec 16 19:16:49 GMT 2023` Edited by `admin` on `Sat Dec 16 19:16:49 GMT 2023`
Nucleic Acid Type	GENE
Nucleic Acid Subtype	TRANSGENE
Sequence Type	COMPLETE
Record UNII	63SFS9Q5ZB
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

Raxorulimogene belzovacirepvec transgene (IgGL–T2A-αCTLA4-IgGH)

Common Name

English

Raxorulimogene belzovacirepvec transgene (anti-cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) immunoglobulin G1 γ1-chain fused via a synthetic T2A peptide with human immunoglobulin kappa chain (anti-CTL4 antibody) with the Igκ signal sequence for

Common Name

English

Code System Code Type Description

FDA UNII

63SFS9Q5ZB

Created by admin on Sat Dec 16 19:16:49 GMT 2023 , Edited by admin on Sat Dec 16 19:16:49 GMT 2023

PRIMARY

Sugar	Site Range	Site Count
Deoxyribose (DNA)	1_1-1_2184	2184 / 2184

Linkage	Site Range	Site Count
Phosphate	1_2-1_2184	2183 / 2183